Local and systemic immune response to a microencapsulated sub-unit vaccine for plague

Vaccine

Volumn 14, Issue 17-18, 1996, Pages 1613-1619

  Williamson, E Diane ^a   Sharp, Gregory J E ^b   Eley, Stephen M ^a   Vesey, Peter M ^a,c   Pepper, Teresa C ^b   Titball, Richard W ^a   Alpar, H Oya ^b  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^b ASTON UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF SUNDERLAND   (United Kingdom)

Author keywords

microencapsulated vaccine; plaque; protective sub units

Indexed keywords

BACTERIAL VACCINE; SUBUNIT VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; ENCAPSULATION; FEMALE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PLAGUE; PRIORITY JOURNAL; YERSINIA PESTIS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; BACTERIAL VACCINES; CHOLERA TOXIN; DRUG COMPOUNDING; FEMALE; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; SPLEEN; T-LYMPHOCYTES; TITRIMETRY; YERSINIA PESTIS;

EID: 0030464421     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00151-X     Document Type: Article

References (41)

1. 1 Butler, T. In: Plague and Other Yersinia Infections. Plenum Press, New York, 1983
2. 2 Marshall, J.D., Bartelloni, P.J., Cavanaugh, D.C., Kadull, P.J. and Meyer, K.F. Plague immunisation. II. Relation of adverse clinical reactions to multiple immunisations with killed vaccines. J. Infect Dis. 1974, 129, S19-S25
3. 3 Meyer, K.F. Effectiveness of live or killed plague vaccines in man. Bull. WHO 1970, 42, 653-666
4. 4 Meyer, K.F., Cavanaugh, D.C., Bartelloni, P.J. and Marshall, J.D. Plague immunisation. I. Past and present trends. J. Infect Dis. 1974, 129Suppl., 13-18
5. 5 Cavanaugh, D.C., Eisberg, B.L., Llewellyn, C.H. et al. Plague immunisation. V. Indirect evidence for the efficacy of plague vaccine. J. Infect. Dis. 1974, 129Suppl., 37-40
6. 6 Meyer, K.F., Smith, G., Foster, L., Brookman, M. and Sung, M. Live, attenuated Yersinia pestis vaccine: virulent in non-human primates, harmless to guinea-pigs. J. Infect. Dis. 1974, 129Suppl., 85-120
7. 7 Williamson, E.D., Eley, S.M., Griffin, K.F. et al. A new improved sub-unit vaccine for plague: the basis of protection. FEMS Immun. Med. Microbiol. 1995, 12, 223-230
8. 8 Baker, E.E., Sommer, H., Foster, L.E., Meyer, E. and Meyer, K. F. Studies on immunisation against plague. J. Immun. 1952, 68, 131-145
9. 9 Lawton, W.D., Erdman, R.L. and Surgalla, M.J. Biosynthesis and purification of V and W antigen in Pasteurella pestis. J. Immun. 1963, 91, 179-184
10. 10 Almeida, A., Alpar, H.O. and Brown, M.R.W. Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly(L-lactic acid) microspheres in rats, rabbits and guinea-pigs. J. Pharm. Pharmac. 1993, 45, 198-203
11. 11 Almeida, A.J., Alpar, H.O., Williamson, E.D. and Brown, M.R. Poly(lactic acid) microspheres as immunological adjuvants for orally delivered cholera toxin B sub-unit. Biochem. Soc. Trans. 1992, 20, 316S
12. 12 Conway, B.R., Alpar, H.O. and Lewis, D.A. Studies on the optimisation of loading and release kinetics of interferongamma from polylaclide microspheres. Proc. Int. Symp. Control. Rel. Bioact. Mater. 1994, 21, 284-285
13. 13 O'Hagan, D.T., McGee, J.P., Byle, R. et al. The preparation, characteristaion and pre-clinical evaluation of an orally administered HIV-1 vaccine, consisting of a branched peptide immunogen entrapped in controlled release microparticles. J. Controlled Rel. 1995, 36, 75-84
14. 14 Marx, P.A., Compans, R.W., Gettie, A. et al. Protection against vaginal SIV transmission with microencapsulated vaccine. Science 1993, 260, 1323-1326
15. 15 Offit, P.A., Khoury, C.A., Moser, C.A, Clark, H.F., Kim, J.E. and Speaker, T.J Enhancement of rotavirus immunogenicity by microencapsulation. Virology 1994, 203, 134-143
16. 16 Jones, D.H., McBride, B.W., Jeffery, H., O'Hagan, D.T., Robinson, A. and Farrar, G.H. Protection of mice from Bordetella pertussis respiratory infection using microencapsulated pertussis fimbriae. Vaccine 1995, 13, 675-681
17. 17 Tseng, J., Komisar, J.L., Trout, R.N. et al. Humoral immunity to aerosolised Staphylococcal Enterotoxin B (SEB), a superantigen, in monkeys vaccinated with SEB toxoid-containing microspheres. Infect. Immun. 1995, 63, 2880-2885
18. 18 Brannon-Peppas, L. Recent advances on the use of biodegradable microparticles and nanopartides in controlled drug delivery. Int. J. Pharmaceut. 1995, 116, 1-9
19. 19 Beck, L.R., Cowsar, D.R., Lewis, D.H., Cosgrove, R.J., Lowry, S.L. and Epperly, T. A new long-acting microcapsule system for administration of progesterone. Fertility Sterility 1979, 31, 545-551
20. 20 Jenkins, P.G., Coombes, A.G.A., Yeh, M.K., Thomas, N.W. and Davis, S. Aspects of the design and delivery of microparticles for vaccine applications. J. Drug Targeting 1995, 3, 79-81
21. 21 Eldridge, J.H., Meulbroek, J.A., Staas, J.K., Tice, T.R. and Gilley, R.M. Vaccine-containing biodegradable microspheres specifically enter the gut-associated rymphoid tissue following oral administration and induce a disseminated mucosal immune response. Adv. Exp. Med. Biol 1989, 251, 192-202
22. 22 Tamura, S., Ishihara, K., Miyata, K., Aizawa, C. and Kurata, T. Mechanism of enhancement of the immune responses to influenza vaccine with cholera toxin B subunit and a trace amount of holotoxin. Vaccine 1995, 13, 339-341
23. 23 Holmgren, J. Actions of cholera toxin and the prevention and treatment of cholera. Nature 1981, 292, 413-417
24. 24 Lycke, N. and Holmgren, J. Strong adjuvant properties of cholera toxin on the gut mucosal immune responses to orally presented antigens. Immunology 1986, 59, 301-308
25. 25 Leary, S.E.C., Williamson, E.D., Griffin, K.F., Russell, P., Eley, S.M. and Titball, R.W. Active immunisation with recombinant V antigen from Yersinia pestis protects mice against plague. Infect. Immun. 1995, 63, 2854-2858
26. 26 Williamson, E.D. and Titball, R.W. A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangrene. Vaccine 1993, 11, 1253-1258
27. 27 Smith, P.K., Krohn, R.I., Hermanson, G.T. et al. Measurement of proteins using bicinchoninic acid. Analyt. Biochem. 1985, 150, 76-85
28. 28 Russell, P., Eley, S.M., Hibbs, S.E., Manchee, R.J., Stagg, A.J. and Titball, R.W. A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine 1995, 13, 1551-1556
29. 29 Leonard, J.M. The Arithmetic of Decision-making. The English Universities Press, London, 1971
30. 30 Pierce, N.F. and Gowans, J.L. Cellular kinetics of the intestinal response to cholera toxoid in rats. J. Exp. Med. 1975, 142, 1550-1563
31. 31 Seymour, L., Schacht, E. and Duncan, R. The effect of size of polystyrene particles on their retention within the rat peritoneal compartment, and on their interaction with rat peritoneal macrophages in vitro. Cell Biol. Int. Reports 1991, 15, 277-286
32. 32 Lycke, N., Tsuji, T. and Holmgren, J. The adjuvant effect of Vibrio cholerae and E. coli heat labile enterotoxins is linked to the ability to stimulate cAMP. Eur. J. Immun. 1992, 22, 2277-2281
33. 33 Vajdy, M. and Lycke, N.Y. Cholera toxin adjuvant promotes long-term immunological memory in the gut mucosa to unrelated immunogens after oral immunization. Immunology 1992, 75, 488-492
34. 34 Nashar, T.O. and Hirst, T.R. Immunoregulatory role of H-2 and intra-H-2 alleles on antibody responses to recombinant preparations of B-subunits of Escherichia coli heat-labile enterotoxin (rEtxB) and cholera toxin (rCtxB). Vaccine 1995, 13, 803-810
35. 35 Gizurarson, S., Tamura, S.I., Aizawa, C. and Kurata, T. Stimulation of the transepithelial flux of influenza HA vaccine by cholera toxin B subunit. Vaccine 1992, 10, 101-106
36. 36 McKenzie, S.J. and Halsey, J.A. Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response. J. Immun. 1984, 133, 1818-1822
37. 37 Wu, H.Y. and Russell, M.W. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect. Immun. 1993, 61, 314-318
38. 38 Une, T. and Brubaker, R.R. Roles of V antigen in promoting virulence and immunity in yersiniae. J. Immun. 1984, 133, 2226-2230
39. 39 Nakajima, R. and Brubaker, R.R. Association between virulence of Yersinia pestis and suppression of gamma interferon and tumour necrosis factor alpha. Infect. Immun. 1993, 61, 23-31
40. 40 Une, T., Nakajima, R. and Brubaker, R.R. Roles of V antigen in promoting virulence of yersiniae. Contrib. Microbiol. Immun. 1987, 9, 179-185
41. - Yersinia pestis in Balb/c mice. Infect. Immun. 1989, 57, 1200-1210